Bone Biologics to participate in H.C. Wainwright 28th Global Investment Conference
Bone Biologics Corporation (NASDAQ: BBLG, BBLGW) said it will participate in the H.C. Wainwright 28th Annual Global Investment Conference.
BURLINGTON, MA, Sept.
03, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced that it will participate in the H.C.
Wainwright 28th Annual Global Investment Conf…